Menu
Warning! You won't be able to use the quotation basket until you enable cookies in your Web browser.
Warning! Your Web browser is no longer supported. Please upgrade to a modern browser.

Jonathan Roy

BS

Jonathan Roy Vice President of Pharma Partnerships, Jon is leading Companion Diagnostic development for Leica Biosystems. He has spent the last 10 years focused on companion diagnostic development and implementation globally both at Leica and as Head of Commercial Strategy for Companion Diagnostics at GlaxoSmithKline.

Published Pieces by Jonathan Roy

  • The Value of Multiplex Staining in the Diagnosis of Cancer
    Editorials article
    Current technology allows tumors to be painted with multiple colors, termed multiplex staining. Multiplex staining today used in research, may also assist with cancer diagnoses clinically via: preservation of tissue, improved diagnostic accuracy, and enhanced diagnostic insight.

Want us to feature your writing?

We are looking for more great writers to feature here. Send us a submission and we'll be in touch!

Send your Writing!

Like what you see?

Get more Knowledge Pathway content like this delivered directly to your inbox. Unsubscribe at any time.